Publication | Open Access

Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment

Neuro-oncologyRadiation MedicineRadiation TherapyMedicineBortezomib CombinedNeurologyHigh-grade GliomasCancer TreatmentPhase 2Radiation OncologyOncologyGliomaUpfront Treatment